We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-15.27%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$72.6M
AUM Growth
+$36.2M
Cap. Flow
+$39.4M
Cap. Flow %
54.35%
Top 10 Hldgs %
38.26%
Holding
170
New
94
Increased
8
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$3.55M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$3.01M
3
WPZ
Williams Partners L.P.
WPZ
+$2.75M
4
MPLX icon
MPLX
MPLX
+$2.63M
5
BPL
Buckeye Partners, L.P.
BPL
+$1.73M

Top Sells

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$656K
2
SRE icon
Sempra
SRE
+$284K
3
DTE icon
DTE Energy
DTE
+$260K
4
SE
Spectra Energy Corp Wi
SE
+$258K
5
EIX icon
Edison International
EIX
+$242K

Sector Composition

Rank Sector Weight
1 Energy 48.57%
2 Healthcare 38.33%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
51
Travere Therapeutics
TVTX
$5.33B
$391K 0.54%
28,634
– –
TCP
52
DELISTED
TC Pipelines LP
TCP
$389K 0.54%
+8,068
New +$366K
REGN icon
53
Regeneron Pharmaceuticals
REGN
$68.8B
$381K 0.52%
+1,057
New +$436K
INCY icon
54
Incyte
INCY
$23.5B
$371K 0.51%
+5,113
New +$381K
INO icon
55
Inovio Pharmaceuticals
INO
$79.8M
$353K 0.49%
+3,374
New +$260K
HALO icon
56
Halozyme
HALO
$9.72B
$348K 0.48%
+36,695
New +$345K
MNTA
57
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$344K 0.47%
+37,282
New +$401K
NGL icon
58
NGL Energy Partners
NGL
$1.94B
$303K 0.42%
+40,261
New +$364K
ADXS
59
DELISTED
Advaxis Inc
ADXS
$283K 0.39%
2,089
-127
-6% -$14K
ANAC
60
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$275K 0.38%
5,147
– –
AGEN
61
Agenus
AGEN
$249M
$268K 0.37%
+3,288
New +$222K
MACK
62
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$264K 0.36%
4,013
-254
-6% -$13.3K
SE
63
DELISTED
Spectra Energy Corp Wi
SE
$260K 0.36%
8,481
-9,127
-52% -$258K
FPRX
64
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$257K 0.35%
+6,321
New +$217K
XNCR icon
65
Xencor
XNCR
$1.44B
$242K 0.33%
+18,040
New +$213K
LOXO
66
DELISTED
Loxo Oncology, Inc
LOXO
$238K 0.33%
8,712
-546
-6% -$11.4K
FOLD
67
DELISTED
Amicus Therapeutics
FOLD
$232K 0.32%
+27,420
New +$194K
LXRX icon
68
Lexicon Pharmaceuticals
LXRX
$1.02B
$230K 0.32%
19,267
-1,219
-6% -$12.8K
ADAP
69
DELISTED
Adaptimmune Therapeutics
ADAP
$229K 0.32%
+28,182
New +$230K
PRTK
70
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$226K 0.31%
14,884
-935
-6% -$14.3K
ABUS icon
71
Arbutus Biopharma
ABUS
$865M
$225K 0.31%
+54,471
New +$195K
ATRA icon
72
Atara Biotherapeutics
ATRA
$71.2M
$218K 0.3%
457
-28
-6% -$12.6K
IMMU
73
DELISTED
Immunomedics Inc
IMMU
$218K 0.3%
87,062
-5,418
-6% -$12.2K
ARWR icon
74
Arrowhead Research
ARWR
$12.1B
$216K 0.3%
44,714
-2,835
-6% -$12K
TSRO
75
DELISTED
TESARO, Inc.
TSRO
$216K 0.3%
4,904
-306
-6% -$12.3K
1 2
3
4 5

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, Virtus ETF Advisers held 170 positions worth $72.6M, up 99% from $36.4M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Virtus ETF Advisers deployed $39.4M of net new capital in Q1 2016, opening 94 new positions and adding to 8 existing holdings. Its largest new stake was Energy Transfer Partners L.p.: 127,467 shares worth $4.12M.

By sector, the portfolio is most concentrated in Energy at 49% of assets, up from 27% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Spectra Energy Corp Wi, an estimated $258K trimmed.

  • Virtus ETF Advisers's largest Q1 2016 buy was Energy Transfer Partners L.p.: 127,467 shares worth $4.12M.
  • Virtus ETF Advisers added most to Buckeye Partners, L.P. in Q1 2016, an estimated $1.73M increase.
  • Virtus ETF Advisers's biggest Q1 2016 reduction was Spectra Energy Corp Wi, cutting an estimated $258K.
  • Virtus ETF Advisers fully exited Aegerion Pharmaceuticals in Q1 2016, selling an estimated $656K.
  • Virtus ETF Advisers's ten largest holdings make up 38% of its $72.6M portfolio in Q1 2016.
  • Virtus ETF Advisers opened 94 new positions and closed 17 in Q1 2016.
  • Virtus ETF Advisers's portfolio value rose 99% quarter-over-quarter to $72.6M.

Based on Virtus ETF Advisers's 13F filing for Q1 2016, filed 16 May 2016.